Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 21 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Editorial: Decoding cancer complexity with artificial intelligence and molecular level studies: informatics-driven approaches for therapeutic innovation
    Chandrabose Selvaraj, Krishnendu Bera, Senthilkumar Krishnamoorthi +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  2. Clinical outcomes and toxicity after proton- versus photon-based spatially fractionated radiotherapy for soft-tissue sarcoma: a retrospective cohort
    Adeniyi A. Olabumuyi, Matthew H. Brown, Soha Bazyar +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  3. Rapid disease progression during adjuvant chemotherapy following concurrent chemoradiotherapy and radical resection for rectal sarcomatoid carcinoma: a case report and literature review
    Weiti Chen, Penghong Zeng, Huang Cao +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  4. Discriminating malignancy of pulmonary nodules using a peripheral blood leukocyte DNA methylation-based SEMO network model
    Bingyang Huang, Luyan Shen, Fengling Hu +13
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  5. Case Report: Metachronous colon metastasis of clear-cell renal cell carcinoma seven years after radical nephrectomy
    Yuhang Tian, Xinchun Wu, Yongbai Li +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  6. Association of drainage volume decline trajectories during the first 7 postoperative days with persistent seroma on postoperative day 30 after modified radical mastectomy for breast cancer
    Qingzhao Bian, Xiangyu Wu, Mingkun Cui
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  7. Analysis of prognostic factors for survival after curative resections of clear-cell renal cell carcinoma based on Bayesian networks
    Bin Zhan, Yachun Chen, Hongqian Ke +10
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  8. Pelvic HPV-associated squamous cell carcinoma of unknown primary origin: a case report
    Yinrui Sun, Zhigang Niu, Nuowei Ji +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  9. Advances in platinum-based drug development for cervical cancer therapy
    Donghan Shao, Ping Gao, Qian Wang +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0OncologyCrossref
  10. Exogenous carnitine can modulate oxaliplatin sensitivity in colorectal cancer cells in vitro
    Yufang Fan, Jian Huang, Liqiang Dai +8
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0OncologyCrossref
  11. Medication-Related Osteonecrosis of the Jaw According to Antiresorptive Treatment Indication: Disease Severity and Associated Factors
    Ivona Mihaela Hum, Raluca Maracineanu, Laura Atyim +4
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0OncologyCrossref
  12. Single Versus Double Drainage After Modified Radical Mastectomy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ahmed Abu-Zaid, Yara S. Alseddiqi, Mohammad M. Sarkhouh +11
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0OncologyCrossref
  13. Single-Center External Validation and Calibration of the ACS NSQIP Surgical Risk Calculator in Emergency Colorectal Cancer Surgery
    Ahmet Sencer Ergin, Ahmet İlter Ergin, Alparslan Saylar +4
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0OncologyCrossref
  14. Internal Evaluation of a Machine Learning-Based Random Forest Model for Clinically Relevant Postoperative Pancreatic Fistula After Pancreaticoduodenectomy: Limited Incremental Value of Inflammatory–Nutritional Markers
    Gizem Gunes, Adem Ozcan, Abdulkadir Unsal
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0OncologyCrossref
  15. Mutant KRAS Reprograms Luminal Progenitor Differentiation to Establish a Novel Transformation-Competent Mammary Epithelial Cell State
    Madison N. Wicker, Hye Kyung Lee, Kerry Vistisen +1
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  16. Real-World Implementation of Molecular Testing and Biomarker-Guided Therapies in HR+/HER2− Metastatic Breast Cancer
    Christine Deutschmann, Matthias Filipovic, Dagmar Baha +6
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  17. Real-World Eligibility for FLAURA, FLAURA2, and MARIPOSA in Patients with EGFR-Mutated Advanced NSCLC: A Retrospective Single-Center Study
    Silvia Marchesi, Paolo Ambrosini, Chiara Cavalli +19
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  18. Simple Algorithm for Blood Morphology Analysis (SAMBA): An Artificial Intelligence-Assisted Approach to Identify Peripheral Blood Phenotypes in a Cohort of Patients with Pancreatic Ductal Adenocarcinoma (PDAC)
    Aleksander Wardęszkiewicz, Konrad Kosztowny, Oliwia Grząsiak-Kraj +6
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  19. Associations of Pretreatment Hemoglobin, Body Mass Index, and Leukocyte Count with Acute and Late Toxicity During and After Radiotherapy for Rectal Cancer
    Nouf M. Alzahrani, Alhanouf Alalyani, Raghad Almutairi +11
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  20. Disparities in type 2 diabetes incidence trends during the COVID-19 pandemic in Sweden: a register-based population study
    Josefine Andreasson, Dominik Dietler, Jonas Björk +1
    BMC Public HealthPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  21. A novel murine colorectal cancer cell line mirroring key clinically relevant mutations
    Maggie L. Lesch, Jiyong Zhao, Taylor P. Uccello +17
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0OncologyCrossref
  22. Organ Preservation in Rectal Adenocarcinoma—A Growing Practice With Promise and Pitfalls
    Charles Liu, Mukta K. Krane, Ira L. Leeds
    JAMA Network OpenPeer-reviewedCC BY 4.0OncologyCrossref
  23. Identifying the predictors of time to diagnosis and treatment for people with cancer: a protocol for a cross-sectional survey supported by linked cancer registry data
    Hannah Jongebloed, Sharina Riva, Maria Bechelli +17
    BMJ OpenPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  24. Efficacy of a large language model-driven application for emotion management in breast cancer patients (EMBRACE): protocol for a multicentre randomised controlled trial
    Meiqin Luo, Chongyang Duan, Wenji Li +22
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textOncologyCrossrefPMC
  25. Allogeneic CAR-T, CAR-NK, and in vivo CAR-T for immune-mediated inflammatory diseases: comparative evidence, platform trade-offs, and translational challenges
    Zhenguo Liang, Mengyun Mao, Hui Xie +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0OncologyCrossref